...
首页> 外文期刊>Journal of pharmacology & toxicology. >Synthesis and Studies on Some New Fluorine Containing Hydroxypyrazolines and 1H Pyrazoles-as Possible Antiproliferative Agents
【24h】

Synthesis and Studies on Some New Fluorine Containing Hydroxypyrazolines and 1H Pyrazoles-as Possible Antiproliferative Agents

机译:含有羟基吡唑啉和1H吡唑的一些新氟的合成和研究 - 尽可能抗增殖剂

获取原文
获取原文并翻译 | 示例

摘要

A series of twenty four newly synthesized l-aroyl-3-aryl-5-hydroxy-5-(2,4-dichloro-5-fluorophenyl) pyrazolines (3) and lH-3-aryl-5-hydroxy-5-(2,4-dichloro-5-fluorophenyl)-pyrazoles (6) were tested for cytostatic and cytotoxic effects on in a primary three cell line-one dose anticancer assay against NCI-H 460 (Lung), MCF 7(Breast) and SF 268 (CNS). Proliferation of these cancer cell lines was strongly inhibited by eleven compounds. These eleven compounds were then passed on for evaluation in the full panel of 60 cell lines derived from seven cancer types namely, Lung, Colon, Melanoma, Renal, Ovarian, CNS and Leukemia. These compounds showed antiproliferative activity on the whole cell panel. Compound lH-pyrazole, 6d [3,4-methylenedioxy at C 3] showed highest activity with Growth Inhibition (GIS0) value <10 uM against all tested 60 cell lines except for Leukamia CCRF-CEM, HL-60TB, K-562 cell lines. Whereas hydroxypyrazolines 3i, 3k 3m, 3o, 3p and 3q showed moderate activity with GI50 value <50 uM against all tested 60 cell lines. Compounds 3h, 3c, 6c appear to be less active with GI50 value >100 uM for some of the tested cell lines. Compound 6a appears to be least active with GI50 value >100 uM for almost all the tested cell lines. The Total Growth Inhibition (TGI) and Lethal Concentration (LC50) values for the most active compound [6d] found to be >100 uM for Leukemia cell lines and for the other cell lines these values remain <20 uM and hence prove to be a cytostatic and cytotoxic for these lines. Hence these newly synthesized pyrazole and pyrazoline derivatives showed promising antiproliferative property.
机译:一系列二十四个新合成的L-芳亚芳基-3-芳基-5-羟基-5-(2,4-二氯-5-氟苯基)吡唑啉(3)和LH-3-芳基-5-羟基-5-(测试2,4-二氯-5-氟苯基) - 在初级三种细胞系 - 一种剂量抗癌剂中进行细胞抑制和细胞毒性作用,对NCI-H 460(肺),MCF 7(乳房)和SF进行细胞抑制和细胞毒性作用268(CNS)。通过11化合物强烈抑制这些癌细胞系的增殖。然后将这些11化合物通过了60种细胞系的全部面板中的评估,即患有七种癌症类型,即肺,结肠,黑素瘤,肾,卵巢,CNS和白血病。这些化合物在整个细胞面板上显示了抗增殖活性。化合物LH-吡唑,6d [C 3] [3,4-亚甲基二氧基]显示出具有生长抑制(GISO)的最高活性<10μm,除了Leukamia CCRF-CEM,HL-60TB,K-562细胞之外的所有测试的60个细胞系线条。羟基吡吡啶3i,3k 3M,3o,3p和3q显示与所有测试的60个细胞系的GI50值<50μm的中等活性。化合物3H,3C,6C对于一些测试的细胞系具有Gi50值>100μm的活性较小。化合物6a对于几乎所有测试的细胞系具有Gi50值>100μm的最小活性。最活跃的化合物[6d]的总生长抑制(TGI)和致命浓度(LC50)值,用于白血病细胞系和其他细胞系,这些值保持<20μm,因此证明是一个这些线的细胞抑制和细胞毒性。因此,这些新合成的吡唑和吡唑啉衍生物显示出有前途的抗增殖性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号